CLINICAL_TRIALS ClinicalTrials.gov record update

Exploratory Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01396070
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:37.367901+00:00
Published At: 2017-04-05T00:00:00+00:00
Record Updated At: 2017-04-05
Results Posted At: 2017-04-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-Hodgkin Lymphoma (NHL)", "Cutaneous Lymphoma", "Cutaneous T-cell Lymphoma (CTCL)", "Mycosis Fungoides", "Sezary Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-04-05"
protocolSection.identificationModule.nctId: "NCT01396070"
protocolSection.identificationModule.officialTitle: "Exploratory Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides and S\u00e9zary Syndrome With Variable CD30 Expression Level"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-04-05"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.